Literature DB >> 11161600

Effects of pathway and neuronal aging on the specificity of motor axon regeneration.

T B Le1, O Aszmann, Y G Chen, R M Royall, T M Brushart.   

Abstract

Youth is a strong predictor of functional recovery after peripheral nerve repair, while adulthood is commonly associated with poor outcome. Identification of the factors responsible for this difference could form the basis for strategies to improve regeneration in adults. Preferential reinnervation of motor pathways by motor axons (PMR) occurs strongly in young rats, but is often absent in older animals, and thus parallels the overall trend for superior results in young individuals. These experiments evaluate the individual contributions of peripheral nerve age and motoneuron age to the decline in regeneration specificity (PMR) which accompanies the aging process. The femoral nerves of young and old Lewis rats were removed as inverted "Y" grafts from the femoral trunk proximally to the terminal muscle and cutaneous branches distally. These grafts were transferred from (1) old to young, (2) young to old, (3) old to old, and (4) young to young bilaterally in 10 individuals per group. After 8 weeks of regeneration, reinnervation of cutaneous and muscle branches was assessed by dual labeling with HRP and Fluoro-Gold. Motor neuron regeneration was random in old to old (mean muscle branch (M) = 159, mean cutaneous branch (C) = 168), but PMR was seen when young pathways were used in old animals (M = 163, C = 116). PMR was vigorous when either type of graft was used in young animals (young graft, M = 218, C = 134; old graft, M = 204, C = 127). In this model, motoneuron age appears to be the primary determinant of specificity. However, the pathway also makes significant contributions, as shown by the ability of young pathways to generate specificity in old animals. Manipulation of graft Schwann cell behavior might therefore be an appropriate strategy to improve outcome in older individuals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161600     DOI: 10.1006/exnr.2000.7538

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

1.  Specificity of motor axon regeneration: a comparison of recovery following biodegradable conduit small gap tubulization and epineurial neurorrhaphy.

Authors:  Youlai Yu; Peixun Zhang; Xiaofeng Yin; Na Han; Yuhui Kou; Baoguo Jiang
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

Review 2.  The age factor in axonal repair after spinal cord injury: A focus on neuron-intrinsic mechanisms.

Authors:  Cédric G Geoffroy; Jessica M Meves; Binhai Zheng
Journal:  Neurosci Lett       Date:  2016-11-03       Impact factor: 3.046

3.  Medialization versus reinnervation for unilateral vocal fold paralysis: a multicenter randomized clinical trial.

Authors:  Randal C Paniello; Julia D Edgar; Dorina Kallogjeri; Jay F Piccirillo
Journal:  Laryngoscope       Date:  2011-09-06       Impact factor: 3.325

4.  Matching of motor-sensory modality in the rodent femoral nerve model shows no enhanced effect on peripheral nerve regeneration.

Authors:  David H Kawamura; Philip J Johnson; Amy M Moore; Christina K Magill; Daniel A Hunter; Wilson Z Ray; Thomas H H Tung; Susan E Mackinnon
Journal:  Exp Neurol       Date:  2010-02-01       Impact factor: 5.330

5.  The effect of patient age on the success of laryngeal reinnervation.

Authors:  Meng Li; Donghui Chen; Xianmin Song; Wei Wang; Minhui Zhu; Fei Liu; Yan Li; Shicai Chen; Hongliang Zheng
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-10       Impact factor: 2.503

6.  Adult motor axons preferentially reinnervate predegenerated muscle nerve.

Authors:  M Abdullah; A O'Daly; A Vyas; C Rohde; T M Brushart
Journal:  Exp Neurol       Date:  2013-08-08       Impact factor: 5.330

7.  Neuronal androgen receptor is required for activity dependent enhancement of peripheral nerve regeneration.

Authors:  Patricia J Ward; Rachel A Davey; Jeffrey D Zajac; Arthur W English
Journal:  Dev Neurobiol       Date:  2021-05-02       Impact factor: 3.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.